Czeremszyńska, B., M. Bujko, G. Ibron, A. Onap-Karnak, and S. Nawrocki. 2011. "Treatment Results, Including Clinical Prognostic Factors and MGMT Gene Promoter Methylation, in Patients with Glioblastoma Multiforme in Warmia and Mazury Oncology Centre." Wspolczesna Onkologia 15 (4): 198-202. www.scopus.com.

Izycki, D., K. Gryska, P. Grabarczyk, P. J. Wysocki, A. Jarosińska, S. Nawrocki, D. W. Kowalczyk, and A. Mackiewicz. 2001. Flow Cytometric Cytotoxicity Assay with GFP Gene Modified Target Cells. Advances in Experimental Medicine and Biology. Vol. 495. www.scopus.com.

Karczewska, A., S. Nawrocki, D. Brȩborowicz, V. Filas, and A. Mackiewicz. 2000. "Expression of Interleukin-6, Interleukin-6 Receptor, and Glycoprotein 130 Correlates with Good Prognoses for Patients with Breast Carcinoma." Cancer 88 (9): 2061-2071. www.scopus.com.

Kieszkowska-Grudny, A., M. Rucińska, S. Biedrzycka, and S. Nawrocki. 2012. "Quality of Life of Cervical Cancer Patients After Radical Radio-Chemotherapy Compared with that of the General Population." Nowotwory 62 (3): 168-174. www.scopus.com.

Kozielec, Z., B. Czeremszyńska-Respekta, M. Sulik, S. Nawrocki, and B. Szóstak. 2008. "Histoclinical Parameters of Invasive Aspergillosis in Radiochemotherapy Treated Patient." Polish Annals of Medicine 15 (1): 25-33. www.scopus.com.

Mackiewicz, A., M. Kapcinska, M. Wiznerowicz, J. Malicki, S. Nawrocki, J. Nowak, P. Murawa, et al. 1998. Immunogene Therapy of Human Melanoma. Phase I/II Clinical Trial. Advances in Experimental Medicine and Biology. Vol. 451. www.scopus.com.

Milecki, P., S. Nawrocki, J. Malicki, and G. Stryczyńska. 2001. "Evaluation of an Electronic Portal Imaging Device (Target View, Ge) as a Quality Assurance Tool." Reports of Practical Oncology and Radiotherapy 6 (4): 169-172. www.scopus.com.

Milecki, P., S. Nawrocki, I. Skoneczna, and Z. Kwias. 2003. "Treatment of Bladder Cancer: The Present and the Future." Reports of Practical Oncology and Radiotherapy 8 (1): 25-32. www.scopus.com.

Milecki, P., G. Stryczyńska, T. Stachowski, S. Nawrocki, and Z. Kwias. 2001. "Hormonal Therapy and 3D Conformal Radiotherapy in Prostate Cancer: Early Toxicity of Combined Treatment." Reports of Practical Oncology and Radiotherapy 6 (4): 161-168. www.scopus.com.

Nawrocki, S. and E. Cieślak. 2006. "Advances in the Management of Malignant Glioma Recurrence." Wspolczesna Onkologia 10 (7): 334-339. www.scopus.com.

Nawrocki, S., B. Czeremszyńska-Respekta, A. Makowiecki, Z. Kozielec, and D. Izycki. 2006. "Radiochemotherapy of Glioblastoma Complicated with Systemic Aspergillosis - Case Report." Wspolczesna Onkologia 10 (9): 434-436. www.scopus.com.

Nawrocki, S., A. Karczmarczyk, and E. Cieślak. 2006. "Toxicity of g-Csf Given during Radiotherapy in Lung Cancer." Wspolczesna Onkologia 10 (9): 455-458. www.scopus.com.

Nawrocki, S., M. Krzakowski, E. Wasilewska-Tesluk, D. Kowalski, M. Rucinska, R. Dziadziuszko, and A. Sowa. 2010. "Concurrent Chemotherapy and Short Course Radiotherapy in Patients with Stage IIIA to IIIB Non-Small Cell Lung Cancer Not Eligible for Radical Treatment: Results of a Randomized Phase II Study." Journal of Thoracic Oncology 5 (8): 1255-1262. www.scopus.com.

Nawrocki, S., M. Laciak, D. Izycki, K. Gryska, P. J. Wysocki, P. Grabarczyk, A. Karczewska, et al. 2001. Humoral Responses to Melanoma Vaccine, Genetically Modified with Interleukin 6 and Soluble Interleukin 6 Receptor. Advances in Experimental Medicine and Biology. Vol. 495. www.scopus.com.

Nawrocki, S. and A. Mackiewicz. 1999. "Genetically Modified Tumour Vaccines - Where we are Today." Cancer Treatment Reviews 25 (1): 29-46. www.scopus.com.

Nawrocki, S., P. Murawa, J. Malicki, M. Kapcinska, K. Gryska, D. Izycki, A. Kaczmarek, et al. 2000. "Genetically Modified Tumour Vaccines (GMTV) in Melanoma Clinical Trials." Immunology Letters 74 (1): 81-86. www.scopus.com.

Nawrocki, S., A. Radkowski, M. Górzyński, and D. Izycki. 2006. "Nasopharyngeal Melanoma Treated with Radiotherapy." Wspolczesna Onkologia 10 (10): 525-527. www.scopus.com.

Nawrocki, S., T. Skacel, and T. Brodowicz. 2003. "From Microarrays to New Therapeutic Approaches in Bladder Cancer." Pharmacogenomics 4 (2): 179-189. www.scopus.com.

Nawrocki, S., T. Skacel, and I. Skoneczna. 2002. "Pharmacotherapy of Bladder Cancer - Practice and Prospects." Expert Opinion on Pharmacotherapy 3 (6): 671-679. www.scopus.com.

Nawrocki, S., P. J. Wysocki, and Andrzej. 2001. "Genetically Modified Tumour Vaccines: An Obstacle Race to Break Host Tolerance to Cancer." Expert Opinion on Biological Therapy 1 (2): 193-204. www.scopus.com.

Wojtukiewicz, M. Z., E. Sierko, M. Rybaltowski, E. Filipczyk-Cisarz, E. Staroslawska, J. Tujakowski, K. Lesniewski-Kmak, C. Szczylik, and S. Nawrocki. 2009. "The Polish Cancer Anemia Survey (POLCAS): A Retrospective Multicenter Study of 999 Cases." International Journal of Hematology 89 (3): 276-284. www.scopus.com.

Wysocki, P. J., S. Nawrocki, and A. Mackiewicz. 2001. "The 14th European Immunology Meeting--EFIS 2000. 23-27 September 2000, Poznañ, Poland." Expert Opinion on Biological Therapy1 (1): 135-140. www.scopus.com.